Back

Efficacy and Safety of Sitafloxacin-Containing Regimen for Improved Treatment of Nontuberculous Mycobacterial Lung Disease: A Multi-Center Retrospective Study

2026-01-16 respiratory medicine Title + abstract only
View on medRxiv
Show abstract

ObjectivesTo evaluate the efficacy and safety of sitafloxacin-containing regimens versus non-sitafloxacin therapy in patients with nontuberculous mycobacterial (NTM) pulmonary disease, focusing on sputum/BALF conversion rate, time of sputum/BALF culture conversion and radiographic improvement. MethodsThis retrospective cohort study analyzed 149 adults (76 control group vs. 73 sitafloxacin group) with NTM pulmonary disease treated between 2021 to 2024. Inclusion criteria: (1) Sitafloxacin group:...

Predicted journal destinations